Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

132 ta ish

Ish: Detailed role of microRNA‐mediated regulation of PI3K/AKT axis in human tumors

  1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

    Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram +3

    Maqola201834 iqtibos
    ABI

  2. Breast Cancer Treatment

    Adrienne G. Waks, Eric P. Winer

    Sharh maqola201910 iqtibos
    ABI

  3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

    Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit +6

    Maqola20147 iqtibos
    ABI

  4. Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation

    Alireza Anvarnia, Farzad Mohaddes‐Gharamaleki, Milad Asadi +3

    Sharh maqola20194 iqtibos
    ABI

  5. MicroRNA

    Thomas X. Lu, Marc E. Rothenberg

    Sharh maqola20174 iqtibos
    ABI

  6. The Role of mTOR Signaling as a Therapeutic Target in Cancer

    N. V. Popova, Manfred Jücker

    Sharh maqola20213 iqtibos
    ABI

  7. PI3K/Akt signalling pathway and cancer

    Juan Ángel Fresno Vara, E. Casado, Javier de Castro +3

    Sharh maqola20033 iqtibos
    ABI

  8. The blood–brain barrier and blood–tumour barrier in brain tumours and metastases

    Costas Arvanitis, Gino B. Ferraro, Rakesh K. Jain

    Sharh maqola20193 iqtibos
    ABI

  9. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma

    Farzad Rahmani, Aghigh Ziaeemehr, Soodabeh Shahidsales +6

    Sharh maqola20193 iqtibos
    ABI

  10. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer

    Zhijian Yan, Yiming Xiao, Yiyan Chen +1

    Maqola20193 iqtibos
    ABI

  11. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways

    Zhenhua Gu, Zhixin You, Yucheng Yang +4

    Maqola20212 iqtibos
    ABI

  12. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells

    Fengyan Yu, Herui Yao, Pengcheng Zhu +8

    Maqola20072 iqtibos
    ABI

  13. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects

    Rosalin Mishra, Hima Patel, Samar Alanazi +2

    Sharh maqola20212 iqtibos
    ABI

  14. Ovarian cancer

    Gordon C. Jayson, Elise C. Kohn, Henry C Kitchener +1

    Sharh maqola20142 iqtibos
    ABI

  15. Extracellular miRNA: A Collision of Two Paradigms

    Andrey Turchinovich, Alexander Tonevitsky, Barbara Burwinkel

    Sharh maqola20162 iqtibos
    ABI

  16. miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs

    Cheng‐Gong Liao, Ling‐Min Kong, Ping Zhou +4

    Maqola20142 iqtibos
    ABI

  17. PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges

    Mohammad Ahmed Khan, Vineet Jain, Md. Rizwanullah +2

    Sharh maqola20192 iqtibos
    ABI

  18. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway

    Lu Chen, Dongming Liu, Xianfu Yi +11

    Maqola20202 iqtibos
    ABI

  19. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop

    Qinkai Zhang, Xunzhu Zhou, Maoping Wan +8

    Maqola20212 iqtibos
    ABI

  20. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer

    Shuying He, Wen D. Song, Shudan Cui +4

    Maqola20232 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI